Health products from the United States and Canada can have a misleading label that might mislead consumers, a new report by consumer rights group Consumer Watchdog says.
“The United States is home to the world’s largest private health insurance market and the largest private employer health insurance marketplace,” the report said.
“There are many things that can mislead consumers,” the group said.
“The biggest problem is the misleading labeling of some products on labels, such as a claim for heart health benefits or a claim that a drug can help with heart disease.”
Consumer Watchdog’s report, titled Health Products From the United Kingdom and Canada, found that some health products marketed in the United Nations have the potential to mislead consumers about their efficacy, side effects, and risks.
“Many of these products contain ingredients that can be toxic or even deadly to people with heart or respiratory diseases,” the organization said.
Consumer Watchdogs report found that health products sold in Canada have a total of 638 ingredients that are not listed on the labels of those products.
It also found that the labels for some of those health products include phrases like ‘can prevent heart disease’ or ‘can help prevent stroke and stroke-related deaths’.
In the United Sates, the Health Products Safety Commission (HPSC) has an obligation to inform consumers about the ingredients in health products that they are purchasing.
“This means that we have to be upfront about these ingredients,” said Elizabeth Gaffney, a health product advocate at Consumer Watchdogs.
“We can’t tell people what to expect.
We can’t warn them that these ingredients are harmful or unsafe.”
She said it’s especially important for people to be aware of the possible health risks associated with products that are marketed in Canada and the United states, especially in light of the deaths of a young boy in India who suffered from a heart attack while taking a drug that is still being tested.
“They are taking drugs that are currently being tested and are still under regulatory scrutiny, and we should be very concerned about their safety,” Gaffneys said.
In the report, Consumers Watchdog also highlighted the widespread misuse of these ingredients in healthcare products sold by private health insurers.
In addition to the labels used in the US, the report also found some health product products in Canada that are labelled as safe or effective when they are not.
“Health products labeled as safe in the U.S. and Canada are unsafe when they aren’t,” the watchdog said.
Health products used in Canada are not labelled as effective in Canada.
“The problem is that consumers are misled about the health benefits of these drugs,” Gafney said.
While some of the health products listed on a generic label in the UK and Canada appear to be of low potency, the health product industry is still struggling to come up with effective products that can meet the standards of FDA.
“In Canada, there is still a lack of effective products on the market,” Gaskin said.
Health products in the EU are not yet regulated as such.
It’s not clear how widespread this problem is in the world, but Consumer Watchdd says it’s a real issue and should be addressed by the US government.
“For many years, many countries have been moving to limit and control their use of generic medicines and to limit their marketing of generic drugs to patients who are not their patients,” the consumer advocacy group said in a statement.
“But, these actions by the European Union do not address the real issue that this is a global problem that is not confined to the U!
S., Canada, or Europe.”
The report recommends that the Food and Drug Administration (FDA) and the Food Standards Agency (FSA) look into the claims and labeling of health products in order to identify the real benefits and risks of generic products.
“If you see the word ‘safety’ on the label, you should know that it does not mean the product is safe,” Gagnon said.